Related Experiment Video
Updated: Jun 17, 2026
10:26
Material Formation of Recombinant Spider Silks through Aqueous Solvation using Heat and Pressure
Published on: May 6, 2019
Periplaneta americana Extract-Loaded Spider Silk Protein Particles Embedded in a Thermosensitive Hydrogel for
Hanyi Li1,2, Guiteng Sun1,2, Jiayi Liu1,2
1Yunnan Provincial Key Laboratory of Entomological Biopharmaceutical R&D, College of Pharmacy, Dali University, Dali, Yunnan 671003, China.
ACS Applied Bio Materials
|June 16, 2026
Summary
This study introduces PA-particles-TH, a novel spider silk protein system for vaginal drug delivery. This system enhances drug retention and sustained release, offering a promising approach for gynecological disease treatment.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Gynecological Therapeutics
Background:
- Conventional vaginal drug delivery faces challenges like rapid clearance and poor drug concentration.
- Spider silk protein offers a potential biomaterial for improved drug carrier systems.
Purpose of the Study:
- To develop and evaluate a composite vaginal drug delivery system (PA-particles-TH) using spider silk protein particles loaded with Periplaneta americana extract.
- To assess the system's drug loading, release kinetics, stability, biocompatibility, and in vivo performance.
Main Methods:
- Spider silk protein particles (PA-particles) were prepared via self-assembly and loaded with PA extract.
- PA-particles were incorporated into a thermosensitive hydrogel (TH) to form the PA-particles-TH composite.
- Drug loading, encapsulation efficiency, particle size, degradation, cytotoxicity, hemocompatibility, and vaginal retention were evaluated.
Main Results:
- Optimized PA-particles showed 9.02% drug loading and 57.88% encapsulation efficiency.
- The PA-particles-TH formulation exhibited sustained drug release over 24 hours and prolonged vaginal retention.
- The system demonstrated good biocompatibility, with no significant cytotoxicity or vaginal irritation.
Conclusions:
- Spider silk protein-based carriers show potential for enhanced vaginal drug delivery.
- The PA-particles-TH system offers a promising strategy for treating gynecological diseases with improved therapeutic outcomes.
Related Concept Videos
01:21Intrauterine Drug Delivery Systems
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...